World Manufacturing Convention: Anhui's Evolution: Agricultural Heartland to Tech Powerhouse
By the shores of Chaohu Lake, the Hefei Binhu International Convention and Exhibition Center will host the 2024 World ...
China's New Energy Company VREMT Showing Muscle at EVA
Electric Vehicles Expo at Automechanika concluded successfully on September 14, 2024. It is the first time for Geely Holding ...
PAPÉ GROUP: Papé Kenworth Enters Dealer Agreement With Mullen Automotive
EUGENE, OR / ACCESSWIRE / September 20, 2024 / Papé Kenworth is thrilled to announce its newest partnership agreement with ...
Baseus Technology (HK) Co., Ltd: Baseus Announces New Line of
As a company that designs products to be practical, reliable, and based on users, the new releases are curated to make ...
Huawei Cloud: Thrive with the Cloud and Reshape Industries with AI
At HUAWEI CONNECT 2024, Executive Director of the Board of Huawei and CEO of Huawei Cloud Zhang Ping'an delivered a keynote ...
Ipsen Pharma: Ipsen's Iqirvo® (elafibranor) approved in the European Union as first new treatment for primary biliary cholangitis in nearly a decade
European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for primary biliary cholangitis (PBC), a rare liver diseaseApproval follows posit ...
Singular Research Initiates Coverage on Oportun Financial Corp with a Buy Rating and a $5.50 Price Target
LOS ANGELES, CA / ACCESSWIRE / September 20, 2024 / Singular Research initiates coverage on Oportun Financial Corp (NASDAQ:OPRT), a leading financial services company focused on providing credit to un ...
Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / September 20, 2024 / RedChip Companies will air interviews with Nova Minerals Limited (Nasdaq:NVA) and Soligenix Inc. (Nasdaq:SNGX) on the RedChip Small Stocks, Big Money sh ...
Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed
Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1]. The trial investigated ...
GENinCode Plc: DISCOVER FH Collaboration With Family Heart Foundation, UT Southwestern, and Partners
LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular diseaseOXFORD, ENGLAND / ACCESSWIRE / September 20, 2024 / GENinCode Plc (AIM:GENI), the genetics compa ...
Focus Universal Inc. Announces Listing Transfer to Nasdaq Capital Market
ONTARIO, CA / ACCESSWIRE / September 20, 2024 / Focus Universal Inc. (NASDAQ:FCUV) ("Focus" or the "Company"), a provider of patented hardware and software design technologies for Internet of Things ( ...
Funnel: New Report Finds Triple Threat Facing Marketing Agencies, Including AI
Research from Funnel outlines the mounting risks facing marketing agencies and the opportunities for adaptation STOCKHOLM, Sept. 20, 2024 /PRNewswire/ -- Funnel ( the marketing ...